nknown Diabetes in Patients with Trigger Finger

Completed

• Conditions: stenosing tenosynovitis; trigger finger; 10043237

• Registration Number: NL-OMON38857
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

Patients who presented with a trigger finger at the outpatient clinic of the VUmc or The Hand Clinic in 2012 are eligible for this study.
Patients are 18 years or older
Patients are treated within 6 months after diagnosis with Kenacort injection (once or twice), surgery or a combination of these therapies.

Exclusion Criteria

Time between diagnosis and last treatment is longer than 6 months
History of/or current serious concomitant disease (i.e. macrovascular, liver, renal, untreated thyroid, malignancy);
Pregnancy;
Substance and/or alcohol abuse;
Unable to fill in and complete informed consent and questionnaire.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Prevalence of (undiagnosed) (pre-)diabetes </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Outcomes of the treatment.<br /><br><br /><br>Patient reported:<br /><br>Q-DASH (Quick DASH-DLV)<br /><br>Satisfaction (Patient Satisfaction, van Lankveld et al. 2000, JHS)<br /><br>VAS pain scale<br /><br><br /><br>Function:<br /><br>Range of motion<br /><br>Precence of a click<br /><br><br /><br></p><br>